EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1

Active Implantable Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 90/385/EEC on Active Implantable Medical Devices, 20 July 1990, amended by Directive 2007/47/EC, 21 September 2007

This list contains hazardous substances for purposes of Directive 90/385/EEC on active implantable medical devices, particularly as regards Article 3 and Annex I (Essential Requirements). This non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Please note that Regulation (EU) 2017/745 on medical devices has repealed Directive 90/385/EEC and begun to apply from 26 May 2021. Nevertheless, Article 120 of the Regulation provides for a transitional period allowing medical devices, under specified conditions (e.g., placed on the market prior to 26 May 2021), to continue to comply with the Directive. In accordance with the fourth paragraph of Article 120, this period ends 26 May 2025.

Last updated 18 April 2024. Database contains 4753 unique substances/entries.

Filter the list

Showing 2,351 - 2,400 of 4,753 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU_BA Directive 2000/54/EC	EU REACH: List of SVHC
Formaldehyde, oligomeric reaction products with aniline	500-036-1	25214-70-4			yes
formaldehyde ...%	200-001-8	50-00-0	Carc. 1B; Muta. 2; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1
forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea	614-346-0	68157-60-8	Carc. 2
Foots oil (petroleum); Foots oil [ complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predomi nantly of branched chain hydro carbons having carbon numbers predominantly in the range of C20 through C50.] A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.	265-171-8	64742-67-2	Carc. 1B
Foots oil (petroleum), silicic acid-treated; Foots oil [A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.] A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.	308-127-6	97862-77-6	Carc. 1B
Foots oil (petroleum), hydrotreated; Foots oil	295-394-6	92045-12-0	Carc. 1B
Foots oil (petroleum), clay-treated; Foots oil [A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predomi nantly of branched chain hydro carbons with carbon numbers predominantly in the range of C20 through C50.] A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.	300-226-2	93924-32-4	Flam. Gas 1; Press. Gas; Carc. 1B
Foots oil (petroleum), carbon-treated; Foots oil [A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.] A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.	308-126-0	97862-76-5	Carc. 1B
Foots oil (petroleum), acid-treated; Foots oil [A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.	300-225-7	93924-31-3	Flam. Gas 1; Press. Gas; Carc. 1B
Fonsecaea pedrosoi	-	-		F Fungi
Fonsecaea compacta	-	-		F Fungi
fonofos (ISO); O-ethyl phenyl ethylphosphonodithioate	213-408-0	944-22-9	Acute Tox. 1; Acute Tox. 2
fomesafen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide	276-439-9	72178-02-0	Acute Tox. 4
folpet (ISO);N-(trichloromethylthio)phthalimide	205-088-6	133-07-3	Carc. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
flusilazole (ISO); bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane	617-717-5	85509-19-9	Carc. 2; Repr. 1B; Acute Tox. 4
flurochloridone (ISO); 3-chloro-4-(chloromethyl)-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one	262-661-3	61213-25-0	Repr. 1B; Acute Tox. 4; Skin Sens. 1
fluquinconazole (ISO);3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one FLUQUINCONAZOLE	411-960-9	136426-54-5	Acute Tox. 3; STOT RE 1; Acute Tox. 4; Skin Irrit. 2
fluorotripentylstannane	243-546-7	20153-49-5	Acute Tox. 4
fluorotrihexylstannane	243-547-2	20153-50-8	Acute Tox. 4
fluorosulphonic acid	232-149-4	7789-21-1	Acute Tox. 4; Skin Corr. 1A
fluorosilicic acid ... %	241-034-8	16961-83-4	Skin Corr. 1B
fluorosilicates, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 4
fluoroboric acid ... %	240-898-3	16872-11-0	Skin Corr. 1B
fluoroacetic acid	205-631-7	144-49-0	Acute Tox. 2
fluoroacetates, soluble	-	-	Acute Tox. 2
fluorine	231-954-8	7782-41-4	Press. Gas; Ox. Gas 1; Acute Tox. 2; Skin Corr. 1A
Fluoribacter bozemanae	-	-		B Bacteria and similar species
Fluoranthene	205-912-4	206-44-0			yes
flumioxazin (ISO); 2-[7-fluoro-3-oxo-4- (prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3 (2H)-dione	600-425-7	103361-09-7	Repr. 1B
flumetralin (ISO); N-(2-chloro-6-fluorobenzyl)-N-ethyl-α, α,α-trifluoro-2,6-dinitro-p-toluidine	613-108-3	62924-70-3	Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
flufenoxuron (ISO); 1-(4-(2-cloro-α, α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea FLUFENOXURON	417-680-3	101463-69-8	Lact.
flufenacet (ISO);N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide	604-290-5	142459-58-3	Acute Tox. 4; STOT RE 2; Skin Sens. 1
fluenetil (ISO); 2-fluoroethyl biphenyl-4-ylacetate	-	4301-50-2	Acute Tox. 1; Acute Tox. 2
flubenzimine (ISO);N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2- ylidene]aniline	253-703-1	37893-02-0	Eye Irrit. 2
fluazinam (ISO); 3-chloro-N-[3- chloro-2,6-dinitro-4-(trifluor omethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine	616-712-5	79622-59-6	Repr. 2; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1A
fluazifop-P-butyl (ISO); butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate	616-669-2	79241-46-6	Repr. 2
fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate	274-125-6	69806-50-4	Repr. 1B
flonicamid (ISO); N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide	605-127-0	158062-67-0	Acute Tox. 4
flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin FLOCOUMAFEN	421-960-0	90035-08-8	Repr. 1B; Acute Tox. 1; STOT RE 1
Flexal virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Flavobacterium meningosepticum	-	-		B Bacteria and similar species
fipronil (ISO); (±)-5-amino-1-(2,6-dichloro-α,α,α-trifluoro-para-tolyl)-4-trifluoromethylsulfinyl-pyrazole-3-carbonitrile	424-610-5	120068-37-3	Acute Tox. 3; STOT RE 1
ficin	232-599-1	9001-33-6	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1
ferbam (ISO); iron tris(dimethyldithiocarbamate)	238-484-2	14484-64-1	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
fentin hydroxide (ISO); triphenyltin hydroxide	200-990-6	76-87-9	Carc. 2; Repr. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
fentin acetate (ISO); triphenyltin acetate	212-984-0	900-95-8	Carc. 2; Repr. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
fenthion (ISO); O, O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate	200-231-9	55-38-9	Muta. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 1
fensulfothion (ISO); O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate	204-114-3	115-90-2	Acute Tox. 1; Acute Tox. 2
fenson (ISO); 4-chlorophenyl benzenesulphonate	201-274-6	80-38-6	Acute Tox. 4; Eye Irrit. 2
fenpyroximate (ISO); tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate	603-792-1	134098-61-6	Acute Tox. 3; Acute Tox. 2; Skin Sens. 1B

Showing 2,351 - 2,400 of 4,753 results.

Export search results to:

EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1

EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1

Active Implantable Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 90/385/EEC on Active Implantable Medical Devices, 20 July 1990, amended by Directive 2007/47/EC, 21 September 2007

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 18 April 2024. Database contains 4753 unique substances/entries.

Footer Nav Items